Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Islander

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neuromuscular Disorders : NMD|March 1, 1995
Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosedG Islander, K G Henriksson, E Ranklev-Twetman
Acta Anaesthesiologica Scandinavica|April 14, 2007
Male preponderance of patients testing positive for malignant hyperthermia susceptibilityG Islander, K Rydenfelt, E Ranklev, et al.
Acta Anaesthesiologica Scandinavica|October 9, 2002
Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibilityG Islander, H Ording, D Bendixen, et al.
Acta Anaesthesiologica Scandinavica|May 1, 1996
Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probandsG Islander, D Bendixen, E Ranklev-Twetman, et al.
Clinical Genetics|December 1, 1996
Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markersT H Fagerlund, G Islander, E Ranklev-Twetman, et al.
Acta Anaesthesiologica Scandinavica|November 4, 2006
Malignant hyperthermia and central core disease causative mutations in Swedish patientsM Broman, G Islander, C R Müller, et al.
Clinical Genetics|June 1, 1997
Malignant hyperthermia susceptibility, an autosomal dominant disorder?T H Fagerlund, G Islander, E Ranklev Twetman, et al.
Clinical Genetics|July 1, 1995
A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermiaT H Fagerlund, G Islander, E R Twetman, et al.
Clinical Genetics|April 1, 1996
RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibilityT Fagerlund, H Ording, D Bendixen, et al.
Clinical Genetics|March 31, 1998
Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutationT H Fagerlund, H Ording, D Bendixen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neuromuscular Disorders : NMD|March 1, 1995
Malignant hyperthermia susceptibility without central core disease (CCD) in a family where CCD is diagnosedG Islander, K G Henriksson, E Ranklev-Twetman
Acta Anaesthesiologica Scandinavica|April 14, 2007
Male preponderance of patients testing positive for malignant hyperthermia susceptibilityG Islander, K Rydenfelt, E Ranklev, et al.
Acta Anaesthesiologica Scandinavica|October 9, 2002
Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibilityG Islander, H Ording, D Bendixen, et al.
Acta Anaesthesiologica Scandinavica|May 1, 1996
Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probandsG Islander, D Bendixen, E Ranklev-Twetman, et al.
Clinical Genetics|December 1, 1996
Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markersT H Fagerlund, G Islander, E Ranklev-Twetman, et al.
Acta Anaesthesiologica Scandinavica|November 4, 2006
Malignant hyperthermia and central core disease causative mutations in Swedish patientsM Broman, G Islander, C R Müller, et al.
Clinical Genetics|June 1, 1997
Malignant hyperthermia susceptibility, an autosomal dominant disorder?T H Fagerlund, G Islander, E Ranklev Twetman, et al.
Clinical Genetics|July 1, 1995
A search for three known RYR1 gene mutations in 41 Swedish families with predisposition to malignant hyperthermiaT H Fagerlund, G Islander, E R Twetman, et al.
Clinical Genetics|April 1, 1996
RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibilityT Fagerlund, H Ording, D Bendixen, et al.
Clinical Genetics|March 31, 1998
Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutationT H Fagerlund, H Ording, D Bendixen, et al.
Pageof 3